Latest

Latest FDA News | Page 6

  • Latest FDA news stories and updates. What is happening today? All recent FDA news and developments. Live coverage and timeline of FDA. All you need to know about FDA.
Orthocell completes all nerve repair surgeries in Remplir US market authorisation study
‘Reaching this point in the development of bisantrene is a major milestone and accomplishment’
Telix announces QDOSE platform partnership for personalised dosimetry in radiopharmaceutical therapy
What you need to know about new treatments for children with peanut allergies
Creating Remote Sensor To Detect Health Troubles
New drug shows promise in treating chronic kidney disease
Mesoblast says US FDA feedback indicates support for accelerated approval pathway
Vaccine-skeptical mothers say bad health care experiences made them distrust the medical system
Opill, the first over-the-counter birth control pill, will be on shelves soon − here are some key things to know
Asthma meds have become shockingly unaffordable − but relief may be on the way
Low-Cost Liquid Tames Tooth Decay
Neuren Pharmaceuticals reports fourth quarter royalties from DAYBUE sales
New study: Diabetes drug linked to fewer hospitalisations for infections, anemias and obstructive airway diseases
Nicotine pouches are being marketed to young people on social media. But are they safe, or even legal?
A drug to treat frostbite is finally available
Certa Therapeutics’ FT011 granted US FDA fast track for systemic sclerosis
Nearly 2 million Americans are using kratom yearly, but it is banned in multiple states: A pharmacologist explains the controversy
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
Light, labor inducer could treat skin condition
Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
Avoiding cloudy messaging: Vape prevention campaigns face challenges
AVITA Medical signs US distribution agreement with Stedical Scientific
Vaping labels challenge: Encouraging adults, dissuading kids
Jane Morgan and Brian Leedman Appointed to the Board of Directors of BlinkLab – Early and Accurate Detection of Autism using an…
GYDER® Surgical announces successful first surgical cases in India
A novel switch to turn genes on/off, promising step toward safer gene therapy
Closing in on the ultimate quest to regenerate insulin in pancreatic stem cells
From today, new regulations make it harder to access vapes. Here’s what’s changing
What’s the difference between physical and chemical sunscreens? And which one should you choose?
Florey researchers changing the world of brain and mental health conditions
UniSA researchers win $15m in NHMRC grants to address some of society’s biggest health challenges
FDA grants fast-track designation for EnGeneIC’s pancreatic cancer candidate
Victorian Government backs the development of Cyban’s brain injury technology
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
UW research finds that mailing HPV test kits directly to patients increases cervical cancer screening rates
Island Pharmaceuticals doses first cohort in ISLA-101 Single Ascending Dose study
Orthocell announces final positive results of cell therapy in ‘tennis elbow’ study
Truqap (capivasertib) plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
US FDA grants Argenica Therapeutics’ ARG-007 orphan drug designation
Neuren Pharmaceuticals completes Phelan-McDermid syndrome Phase 2 trial 
Alzheimer’s lecture focuses on new treatment developments and diagnostics
Student-designed artificial heart pumped to beat world’s best at first ever Heart Hackathon
US Food and Drug Administration accepts for review AstraZeneca’s Supplemental Biologics License Application for self-administration of FluMist Quadrivalent
FDA grants Certa Therapeutics’ FT011 orphan drug designation for systemic sclerosis
FDA funds Australian research for better, affordable asthma inhalers
Tagrisso plus chemotherapy granted Priority Review in the US for patients with EGFR-mutated advanced lung cancer
Finally the answer to the dreaded paper straw

© 2026 - The National Tribune Australia